Nasdaq: RLYBStockForm 13F30 Jun 2026

Hedge funds that hold Rallybio Corp Nasdaq: RLYB

CUSIP 75120L209 · who reports it, how much, and how much it matters to them

6 of the 720 hedge fund managers we track reported shares of Rallybio Corp (Nasdaq: RLYB) on Form 13F for 30 June 2026. Between them they reported USD 28m. The largest position belongs to Citadel Advisors, at USD 13m. The manager with the most riding on it is Rangeley Capital, where it is 1.5% of the reported book.

Managers reporting it6of 720 we track
Value they reportUSD 28mshares only, 30 Jun 2026
Funds they run92with a file on PPLI.com
Largest positionUSD 13mCitadel Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight1.5%Rangeley Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

6 managers, USD 28m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Rallybio Corp, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Citadel Advisors32 funds on PPLI.comUSD 13m0.0%
2Viking Global Investors4 funds on PPLI.comUSD 8.4m0.0%
3Renaissance Technologies13 funds on PPLI.comUSD 3.2m0.0%
4Almitas Capital2 funds on PPLI.comUSD 1.9m0.5%
5Rangeley Capital6 funds on PPLI.comUSD 1.7m1.5%
6Two Sigma Investments35 funds on PPLI.comUSD 266,0000.0%
Next: where it matters most
Where it matters most

For Rangeley Capital it is 1.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Rangeley CapitalUSD 1.7m1.5%
2Almitas CapitalUSD 1.9m0.5%
3Viking Global InvestorsUSD 8.4m0.0%
4Renaissance TechnologiesUSD 3.2m0.0%
5Citadel AdvisorsUSD 13m0.0%
6Two Sigma InvestmentsUSD 266,0000.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Rallybio Corp

What is the ticker symbol of Rallybio Corp?

Rallybio Corp trades under the symbol RLYB on the Nasdaq. Its CUSIP, the code used on Form 13F, is 75120L209.

Which hedge funds own Rallybio Corp (Nasdaq: RLYB)?

6 of the 720 hedge fund managers PPLI.com tracks reported Rallybio Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 13m), Viking Global Investors (USD 8.4m), Renaissance Technologies (USD 3.2m), Almitas Capital (USD 1.9m) and Rangeley Capital (USD 1.7m).

How many hedge funds hold Rallybio Corp?

6 managers in our coverage reported it, and between them they run 92 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Rallybio Corp?

Rangeley Capital, where the position was 1.5% of the reported 13F book at 30 June 2026.

Does this show who is short Rallybio Corp?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rallybio Corp or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.